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Gynecomastia is a common condition characterized by the
benign excessive development of breast tissue in boys and
men. The condition is caused by excessive estrogen pro-
duction that induces an increase in the estrogen-to-
androgen ratio.1
46,XX male syndrome is a rare disease characterized by
male phenotype expression in an individual with XX sex
chromosomes and no Y chromosome. The presence,
absence, or mutation of the SRY gene can result in a diverse
set of phenotypic expressions. The condition is typically
diagnosed in late adolescence or adulthood, as it manifests
in infertility and/or small testicular size. It is particularly
difficult to differentiate pathological from physiological
gynecomastia in adolescents. Here, we report the case of a
17-year-old boy with the 46,XX male syndrome who pre-
sented to our hospital with gynecomastia.
2. Case report
A pediatric patient aged 17 years and 6 months was
admitted to our hospital with the chief complaint of gy-
necomastia that had been worsening for 1 year. The patient* Corresponding author. Department of Pediatrics, Chonbuk Na-
tional University Medical School, Keumam-dong, Jeonju 561-712,
South Korea.
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He reported no family history of gynecomastia, had not
received any pharmacological treatment, and did not have
testicular trauma. Physical examination revealed Tanner
Stage IV symmetrical breast development and pubic hair.
The patient experienced tenderness in the breasts, and
bilateral palpable concentric firm masses were noted
(Figure 1 (A), (B)). His external genitalia were symmetrical,
and the volume of both testes was 6 mL.
We examined the patient’s hormone levels to elucidate
the reason for the gynecomastia. We observed increased
luteinizing hormone (LH; 22.6 mIU/mL; normal range:
0.4e7.0 mIU/mL), follicle-stimulating hormone (FSH;
40.8 mIU/mL; normal range: 2.6e11.0 mIU/mL), and
estradiol (8.34 pg/mL; normal range: 1.0e3.6 pg/mL)
levels. By contrast, the patient’s testosterone levels were
lower than normal (2.87 ng/mL; normal range: 3.5e9.7 ng/
mL). A gonadotropin-releasing hormone stimulation test
revealed that the maximum serum LH and FSH levels were
74.8 mIU/mL and 59.3 mIU/mL, respectively. The serum
levels of alpha-fetoprotein, beta-human chorionic gonado-
tropin, prolactin, cortisol, dehydroepiandrosterone, growth
hormone, and adrenocorticotrophic hormone and thyroid
function test were all within the reference range. Hence,
the patient was diagnosed with hypergonadotropic
hypogonadism.
We then performed a blood chromosome analysis that
revealed a 46,XX karyotype. Because of the relatively
normal male genitalia with small testis in men with the
46,XX genotype, we conducted a multiplex polymerasey Elsevier Taiwan LLC. All rights reserved.
Figure 1 Symmetrical gynecomastia and genetic analyses. (A) Anterior view, (B) lateral view, (C) Chromosome analysis and (D)
polymerase chain reaction analysis for the SRY gene.
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obtained from the patient (Figure 1 (C), (D)). Pelvic mag-
netic resonance imaging revealed that both scrotums con-
tained testicles, although the testicles were small. No
female reproductive organs were seen on imaging. The size
of the patient’s penis was found to be normal.
After the final diagnosis of 46.XX SRY-positive male
syndrome was made, the patient consistently received
monthly testosterone treatments and underwent liposuc-
tion surgery for gynecomastia.3. Discussion
Gynecomastia, which affects about 60% of all boys during
adolescence between the ages of 13 years and 14 years,
induces an increase in estradiol over testosterone produc-
tion.1 By late adolescence, testosterone production begins
to increase more significantly, allowing the adolescent to
recover normal conditions.2 Consequently, gynecomastia is
typically asymptomatic during late adolescence and spon-
taneously regresses.3
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mastia accompanied by hypergonadotropic hypogonadism.
The patient’s hypogonadism was primarily caused by
testicular failure that likely caused decreased testosterone
synthesis and an increase in the testosterone-to-estradiol
conversion, which ultimately caused gynecomastia.2
The 46,XX male syndrome was first reported by de la
Chapelle et al4 in 1964. It is a rare condition only affecting
one in 20,000e25,000 male newborns. The incidence rates
do, however, differ by region.5 In general, cases of 46,XX
male syndrome are categorized according to the presence of
the SRY gene. In a previous study, 80% of 46,XX cases were
SRY-positive.6 The morphology of the external genitalia and
masculinization are often normal in 46,XX SRY-positive men.
Before puberty, these individuals typically do not show any
clinical symptoms; however, during late adolescence or
adulthood, 46,XX SRY-positive men often present with
infertility or small testicular size. A diagnosis of 46,XX male
syndrome is then typically made by chromosomal analysis.7
The patient in the present case was also SRY-positive. His
external genitalia were normal, although his testes were
small. 46,XX SRY-negative males can be diagnosed based on
abnormal virilization of their external genitalia after birth.
46,XX male syndrome can be treated with testosterone
replacement that will induce normal adolescent develop-
ment and promote psychological stability. Future coun-
seling and treatment regarding any residual psychological
issues and infertility are also deemed necessary. Further-
more, surgical corrections to correct any morphological
abnormalities of the external genitalia should be
performed.
In conclusion, a male adolescent who exhibits symptoms
of gynecomastia and hypogonadism should not only undergoroutine biochemical tests for thyroid, liver, and kidney
function, but also evaluations of LH, FSH, testosterone,
estradiol, and prolactin levels. When the patient is diag-
nosed with hypergonadotropic hypogonadism, chromosomal
and SRY gene testing should also be performed to aid with
the differential diagnosis.Conflicts of interest
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